Lawrence Young
131 - 140 out of 149Page size: 10
Publications
- 2010
- Published
- Published
CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals.
Lawrence Young & Daniel Palmer, 15 Jan 2010, In: Journal of Immunology. 184, 2, p. 1111-20 10 p.Research output: Contribution to journal › Article
- Published
CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus
Peter Searle, Lawrence Young & Daniel Palmer, 1 Mar 2010, In: Molecular Cancer. 9, p. 52 1 p.Research output: Contribution to journal › Article
- Published
Is Human Papillomavirus Viral Load a Clinically Useful Predictive Marker? A Longitudinal Study
Christothea Constandinou-Williams, Stuart Collins, Sally Roberts, Lawrence Young & Paul Murray, 1 Mar 2010, In: Cancer Epidemiology Biomarkers & Prevention. 19, 3, p. 832-837 6 p.Research output: Contribution to journal › Article
- Published
- Published
- Published
Smoking-induced p16 methylation in young women
Yuk Ting Ma, Stuart Collins, Lawrence Young, Paul Murray, 1 Oct 2010, p. Abstract B48.Research output: Contribution to conference (unpublished) › Abstract
- 2011
- Published
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma.
Jane Steele, Ankit Rao, Sarah Berhane, Lucinda Billingham, Gordon Ryan, Lawrence Young & Neil Steven, 10 Feb 2011, In: Gene Therapy. 18, p. 584-593Research output: Contribution to journal › Article
- Published
- 2012
- Published
Contributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
Christopher Dawson, Lawrence Young, 1 Jan 2012, In: Journal of virology. 86, 1, p. 60-68 9 p.Research output: Contribution to journal › Article